It is our novel discovery that FBP1, which is abundantly expressed in HCC tumors, is involved in the suppression of transactivation activity of p53 by physically interacting with p53 as well as its two regulatory proteins BCCIP and TCTP. The gene discussed is FBP1; the disease is hepatocellular carcinoma.